Past Issues

• 8

  Analytical Considerations For Combination Products

  Jennifer Riter, Sr. Director, Analytical Services, West Pharmaceutical Services

• 12

  Optimizing Alkermes’ R&D Model for Success

  Craig Hopkinson, M.D., CMO and Executive Vice President, Research and Development, Alkermes

• 19

  Challenges And Opportunities For Ai In Drug Discovery

  Robert J. Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Pharmaceuticals and Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Pharmaceuticals

• 22

  On Accelerating Bioanalytical Workflow Automation

  Ming Li, Director, Bioanalytical and Biomarker Outsourcing Operations, Alexion, AstraZeneca Rare Disease

• 24

  Taking Data Out Of The Data Center To Build Customerfacing Solutions

  Dave Henderson, CIO, Millennium Health

• 28

  The World Of Omnichannel Comes To Life Sciences: What Digital Transformation Looks Like In The Pharma Industry

  Paul R. Whitacre, PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations, Astellas Pharma US

• 30

  Setting A Culture For Digital Transformation In The Biopharmaceutical Industry

  Ross Kenyon, Associate Director – Modeling, Simulation and Analysis, Regeneron Pharmaceuticals, Inc.